Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Erythropoiesis with endurance training: dynamics and mechanisms

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Upgrading hypertension treatment

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Absent increase in vertebral artery blood flow during l-arginine infusion in hypertensive men

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Coupling between arterial and venous cerebral blood flow during postural change

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Carotid baroreflex function at the onset of cycling in men

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Differential glucose metabolism in mice and humans affected by McArdle disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Cardiac natriuretic peptides

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Distinct non-ischemic myocardial late gadolinium enhancement lesions in patients with type 2 diabetes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Effect of insulin on natriuretic peptide gene expression in porcine heart

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • David Montero
  • Andreas Breenfeldt-Andersen
  • Laura Oberholzer
  • Thomas Haider
  • Jens P Goetze
  • Anne-Kristine Meinild-Lundby
  • Carsten Lundby
Vis graf over relationer

The purpose of the present study was to characterize the progression of red blood cell volume (RBCV) expansion and potential volumetric and endocrine regulators of erythropoiesis during endurance training (ET). Nine healthy, untrained volunteers (age = 27 ± 4 yr) underwent supervised ET consisting of 3-4 × 60 min cycle ergometry sessions per week for 8 wk. Plasma volume (PV), RBCV, and overnight fasting hematological markers were determined before and at weeks 2, 4, and 8 of ET. In addition, plasma erythropoietin (EPO), cortisol, copeptin, and proatrial natriuretic peptide concentrations were measured during a 3-h morning period at baseline and postexercise at weeks 1 and 8 PV increased from baseline (2,405 ± 335 ml) at weeks 2, 4, and 8 (+374 ± 194, +505 ± 156, and +341 ± 160 ml, respectively, P < 0.001). Increases in RBCV from baseline (1,737 ± 442 ml) were manifested at week 4 (+109 ± 114 ml, P = 0.030) and week 8 (+205 ± 109 ml, P = 0.001). Overnight fasting plasma EPO concentration increased from baseline (11.3 ± 4.8 mIU/ml) at week 2 (+2.5 ± 2.8 mIU·ml(-1), P = 0.027) and returned to baseline concentration at weeks 4 and 8 Higher 3-h-postexercise EPO concentration was observed at week 1 (11.6 mIU/ml) compared with week 8 (8.4 ± 3.9 mIU/ml, P = 0.009) and baseline (9.0 ± 4.2 mIU/ml, P = 0.019). Linear relationships between EPO concentration and hematocrit (β = -56.2, P < 0.001) and cortisol (β = 0.037, P < 0.001) were detected throughout the ET intervention. In conclusion, ET leads to mild, transient increases in circulating EPO concentration, concurring with early PV expansion and lowered hematocrit, preceding gradual RBCV enhancement.

OriginalsprogEngelsk
TidsskriftAmerican journal of physiology. Regulatory, integrative and comparative physiology
Vol/bind312
Udgave nummer6
Sider (fra-til)R894-R902
ISSN0363-6119
DOI
StatusUdgivet - 1 jun. 2017

ID: 52044370